Milosz P.
- Country
- Poland
- Department
- Department of Infectious Diseases
Research Overview
Data & Insights
Has run more than one trial at 0 of 38 partner sites.
Specializations
Acute Respiratory Infections
Focus on the management of severe COVID-19 in hospitalized adults.
- Immune modulation strategies
- Early antiviral intervention
- Clinical recovery endpoints
Investigations aim to reduce mortality and preserve lung capacity.
HIV‑1 Therapeutics
Dedicated to novel oral regimens for treatment‑naïve and virologically suppressed HIV‑1 patients.
- Weekly dosing formulations
- Switch strategies from standard of care
- Long‑term virologic suppression
Efforts target simplified adherence and durable viral control.
Broad HIV Treatment Strategies
Explores antiviral activity and combination approaches across the spectrum of HIV infection.
- Monotherapy efficacy assessment
- Fixed‑dose combination development
- Comparative effectiveness versus established regimens
Objective is to expand therapeutic options for diverse patient populations.
Idiopathic Pulmonary Fibrosis
Investigates disease‑modifying agents for idiopathic pulmonary fibrosis (IPF).
- Forced vital capacity endpoints
- Dose‑finding studies
- Safety and tolerability profiling
Research seeks to slow progression and improve functional outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.